We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$9.63B
AUM Growth
+$514M
Cap. Flow
-$223M
Cap. Flow %
-2.32%
Top 10 Hldgs %
52.93%
Holding
102
New
30
Increased
20
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$676M
2
BCR
CR Bard Inc.
BCR
+$435M
3
MBLY
Mobileye N.V.
MBLY
+$254M
4
NXPI icon
NXP Semiconductors
NXPI
+$163M
5
HUN icon
Huntsman Corp
HUN
+$134M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$463M
2
BEAV
B/E Aerospace Inc
BEAV
+$322M
3
MJN
Mead Johnson Nutrition Company
MJN
+$319M
4
WWAV
The WhiteWave Foods Company
WWAV
+$205M
5
LLY icon
Eli Lilly
LLY
+$134M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Communication Services 21.97%
3 Healthcare 21.74%
4 Industrials 5.76%
5 Consumer Discretionary 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTXS
26
DELISTED
Citrix Systems Inc
CTXS
$128M 1.33%
1,606,673
+121,549
+8% +$10.1M
INFO
27
DELISTED
IHS Markit Ltd. Common Shares
INFO
$123M 1.28%
2,790,700
-1,022,902
-27% -$45.6M
CHTR icon
28
Charter Communications
CHTR
$17.9B
$113M 1.17%
334,825
-208,205
-38% -$69.5M
TMH
29
DELISTED
Team Health Holdings Inc
TMH
$105M 1.09%
2,298,900
– –
VEON icon
30
VEON
VEON
$4.09B
$79.9M 0.83%
817,341
+399,964
+96% +$39.4M
ABBV icon
31
AbbVie
ABBV
$468B
$60.5M 0.63%
+835,000
New +$56.1M
BIIB icon
32
Biogen
BIIB
$32B
$57.7M 0.6%
+212,500
New +$56.2M
CLVS
33
DELISTED
Clovis Oncology, Inc.
CLVS
$57.1M 0.59%
610,000
+530,000
+663% +$32.4M
AGN
34
DELISTED
Allergan plc
AGN
$55.3M 0.57%
227,500
-420,000
-65% -$98.7M
NORD
35
DELISTED
Nord Anglia Education, Inc.
NORD
$50M 0.52%
+1,535,000
New +$47.8M
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$48M 0.5%
855,000
+470,000
+122% +$18.8M
HUM icon
37
Humana
HUM
$45.5B
$43M 0.45%
178,500
-20,000
-10% -$4.53M
VRSK icon
38
Verisk Analytics
VRSK
$24.4B
$40.7M 0.42%
+482,827
New +$39.1M
WBMD
39
DELISTED
WebMD Health Corp.
WBMD
$39.8M 0.41%
+679,130
New +$37.8M
ELV icon
40
Elevance Health
ELV
$86.9B
$39.5M 0.41%
+210,000
New +$37.7M
IMMU
41
DELISTED
Immunomedics Inc
IMMU
$37.3M 0.39%
4,227,500
+72,500
+2% +$509K
EXEL icon
42
Exelixis
EXEL
$13.4B
$37.3M 0.39%
1,515,000
-2,000,000
-57% -$42.3M
CAB
43
DELISTED
Cabela's Inc
CAB
$35.9M 0.37%
+605,000
New +$33.5M
KYNB
44
Kyntra Bio
KYNB
$30.4M
$34.6M 0.36%
42,880
+15,600
+57% +$10.9M
RC
45
Ready Capital
RC
$311M
$34.5M 0.36%
2,324,236
– –
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$30.2M 0.31%
+3,000,000
New +$24.1M
TRCO
47
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$30M 0.31%
+735,000
New +$28.8M
RYAAY icon
48
Ryanair
RYAAY
$28.9B
$25.7M 0.27%
597,033
+137,745
+30% +$5.46M
MON
49
DELISTED
Monsanto Co
MON
$25.4M 0.26%
+215,000
New +$25.1M
GNCMA
50
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$23.4M 0.24%
+638,976
New +$23.1M
1
2
3 4

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2017 Portfolio in Review

As of Q2 2017, Thomas Steyer held 102 positions worth $9.63B, up 5.6% from $9.11B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Thomas Steyer's Q2 2017 filing shows 30 new, 20 increased, 19 reduced and 21 closed positions. Its largest new stake was Altaba Inc: 12,427,457 shares worth $677M. The largest sale was Yahoo Inc, an estimated $463M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

  • Thomas Steyer's largest Q2 2017 buy was Altaba Inc: 12,427,457 shares worth $677M.
  • Thomas Steyer added most to Mobileye N.V. in Q2 2017, an estimated $254M increase.
  • Thomas Steyer's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $98.7M.
  • Thomas Steyer fully exited Yahoo Inc in Q2 2017, selling an estimated $463M.
  • Thomas Steyer's ten largest holdings make up 53% of its $9.63B portfolio in Q2 2017.
  • Thomas Steyer opened 30 new positions and closed 21 in Q2 2017.
  • Thomas Steyer's portfolio value rose 5.6% quarter-over-quarter to $9.63B.

Based on Farallon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.